An analysis of a very large patient cohort using the FDA-approved F1Dx MSI test found significantly lower incidences of MSI in cancers of the highest frequencies, where the reference was MSI-PCR or MMR protein IHC [48] (Table 5). The gene discussed is MRC1; the disease is cancer.